medigraphic.com
Órgano oficial de la Sociedad Mexicana de Cirugía Dermatológica y Oncológica, AC

2009, Number 1

<< Back Next >>

Dermatología Cosmética, Médica y Quirúrgica 2009; 7 (1)

Acne. Overview and current therapeutics

Morales TA, Ocampo CJ

Language: Spanish
References: 11
Page: 18-25
PDF size: 143.25 Kb.


ABSTRACT

Acne is one of the ten most frequent dermatoses in dermatology practice. It is very frequent in adolescents. Classification of acne is performed for therapeutic decision. According to its severity it is classified as mild, moderate, and severe. In patients with acne and hormone disorders a multidisciplinary endocrinological study should be carried out. Treatment for acne is topical or systemic. Tretinoin is the drug of choice for the treatment of non-inflammatory acne and should be used as maintenance therapy since it prevents the formation of comedones. It is necessary to reduce the rotational use of antibiotics, topical as well as systemic, to a minimum to prevent bacterial resistance of P. ACNES. Combined topical treatments, especially benzoyl peroxide with clindamycin or erithromycin, reduce bacterial resistance as well as the irritation that benzoyl peroxide could cause. Oral isotretinoin is the therapeutic resource of excellence in cases of severe and moderate acne that do not respond to conventional treatments.


REFERENCES

  1. Cunliffe W. “Natural history of acne”. En: Acne and related disorders, Martin Dunitz, Londres, 1989, 2-10.

  2. Bergfeld WF, Odom RB. “New perspectives on acne”. Clinician 1996; 12(4): 8-17.

  3. Eady EA. “Antibiotic resistance and skin bacteria: Current trends and future prospects. Relevance”. Marks R, Plewig G. En: Acne and related disorders, Martin Dunitz, Londres, 1989, 127-131.

  4. Kaminsky A. Acné. Un enfoque global, 1a ed., Colegio Ibero-Latino ame - ricano de Dermatología (CILAD), Buenos Aires, 2007, 179-181.

  5. Zaenglein AI, Thiboutout D. “Acne vulgaris”. En: Bologna J, Jorizzo J, Rapini L. Dermatology, Mosby, Londres, 2003, 531-544.

  6. Suei Y, Taguchi A, Tanimoto K, Yamada T, Otani K, Fukuda T. “Case report. synovitis, acne, pustulosis, hyperostosis and osteitis (SAPHO) syndrome”. Dentomaxillofac Radiol 1996; 25(5): 287-291.

  7. Goulden V, Clark SM, Cunliffe WJ. “Post-adolescent acne: A review of clinical features”. Br J Dermatol 1997; 136(1): 66-70.

  8. Pochi PE, Shalita AR, Strauss JS, et al. “Report of the Consensus Conference on Acne Classification”. Washington, D.C., 24 y 25 de marzo de 1990. J Am Acad Dermatol 1991; 24(3): 495-500.

  9. Cunliffe JC, Gollnick H. “Topical therapy”. En: Acne. Diagnosis and Management, Martin Dunitz, Londres, 2001, 107-114.

  10. Meynadier J, Alirezai M. “Systemic therapy”. Dermatology 1998; 196(1): 135- 139.

  11. Hanson N, Leachman S. “Safety issues in isotretinoin therapy”. Semin Cutan Med Surg 2001; 20(3): 166-183.




2020     |     www.medigraphic.com